KR101128990B1 - 피부 미백 효능을 가지는 식물 추출물로 이루어진 조성물 및 이를 포함하는 화장료 조성물 - Google Patents
피부 미백 효능을 가지는 식물 추출물로 이루어진 조성물 및 이를 포함하는 화장료 조성물 Download PDFInfo
- Publication number
- KR101128990B1 KR101128990B1 KR1020090099930A KR20090099930A KR101128990B1 KR 101128990 B1 KR101128990 B1 KR 101128990B1 KR 1020090099930 A KR1020090099930 A KR 1020090099930A KR 20090099930 A KR20090099930 A KR 20090099930A KR 101128990 B1 KR101128990 B1 KR 101128990B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- extract
- skin whitening
- skin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 239000002537 cosmetic Substances 0.000 title claims abstract description 16
- 239000000419 plant extract Substances 0.000 title abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 31
- 229940038487 grape extract Drugs 0.000 claims abstract description 6
- 229940069445 licorice extract Drugs 0.000 claims abstract description 6
- 102000003425 Tyrosinase Human genes 0.000 abstract description 18
- 108060008724 Tyrosinase Proteins 0.000 abstract description 18
- 230000002401 inhibitory effect Effects 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 14
- 241000202807 Glycyrrhiza Species 0.000 abstract description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 7
- 229940010454 licorice Drugs 0.000 abstract description 7
- 210000004694 pigment cell Anatomy 0.000 abstract description 7
- 241000219094 Vitaceae Species 0.000 abstract description 6
- 235000021021 grapes Nutrition 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 230000003061 melanogenesis Effects 0.000 abstract description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 abstract 1
- 229960004502 levodopa Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 45
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 28
- 238000012360 testing method Methods 0.000 description 18
- 239000006210 lotion Substances 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000008099 melanin synthesis Effects 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 210000002752 melanocyte Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 4
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 229960004441 tyrosine Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011539 homogenization buffer Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000007332 vesicle formation Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
시료명 | 티로시나제 활성저해율(%) |
0.001중량% 함유 조성물 | 16.9 |
0.01중량% 함유 조성물 | 35.2 |
0.1중량% 함유 조성물 | 78.6 |
1중량% 함유 조성물 | 87.6 |
10중량% 함유 조성물 | 92.5 |
대조군 | 0.30 |
시료명 | 멜라닌생성저해율(%) |
0.001중량% 함유 조성물 | 20.3 |
0.01중량% 함유 조성물 | 38.8 |
0.1중량% 함유 조성물 | 62.4 |
1중량% 함유 조성물 | 54.6 |
10중량% 함유 조성물 | 42.3 |
대조군 | 0.00 |
성분명 | 함량(중량%) | 비고 |
바세린 | 2 | |
스테아린산 | 1 | |
유동파라핀 | 5 | |
모노올레인산폴리옥시에틸렌 소르비탄 | 2 | |
글리세린 | 3 | |
프로필렌글리콜 | 4 | |
트리에탄올아민 | 1.0 | |
향료 | 0.3 | |
방부제 | 0.3 | |
산화방지제 | 0.3 | |
식물 추출물 | 0.001, 0.01, 0.1 1, 10 | 대조군은 함유하지 않음 |
정제수 | to 100 |
시료명 | ΔL값 |
0.001중량% 함유 로션 | 0.4 |
0.01중량% 함유 로션 | 0.7 |
0.1중량% 함유 로션 | 1.1 |
1중량% 함유 로션 | 2.1 |
10중량% 함유 로션 | 2.4 |
대조군 | 0.2 |
시료명 |
점수 | |
24시간 | 48시간 | |
0.001중량% 함유 로션 | 0 | 0 |
0.01중량% 함유 로션 | 0 | 0 |
0.1중량% 함유 로션 | 0 | 0 |
1중량% 함유 로션 | 0 | 0 |
10중량% 함유 로션 | 0 | 0 |
대조군 | 0 | 0 |
Claims (2)
- 감초 추출물 15 내지 25중량%, 신이 추출물 15 내지 25중량%, 황금 추출물 15 내지 25중량%, 포도 추출물 15 내지 25중량%, 상황 추출물 15 내지 25중량%로 이루어진 피부 미백 효능을 가지는 화장료 조성물.
- 감초 추출물 15 내지 25중량%, 신이 추출물 15 내지 25중량%, 황금 추출물 15 내지 25중량%, 포도 추출물 15 내지 25중량%, 상황 추출물 15 내지 25중량%로 이루어진 피부 미백 효능을 가지는 조성물을 유효성분으로 전체 중량 대비 0.001 내지 10 중량% 포함되는 것을 특징으로 하는 화장료 조성물
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090099930A KR101128990B1 (ko) | 2009-10-20 | 2009-10-20 | 피부 미백 효능을 가지는 식물 추출물로 이루어진 조성물 및 이를 포함하는 화장료 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090099930A KR101128990B1 (ko) | 2009-10-20 | 2009-10-20 | 피부 미백 효능을 가지는 식물 추출물로 이루어진 조성물 및 이를 포함하는 화장료 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110043019A KR20110043019A (ko) | 2011-04-27 |
KR101128990B1 true KR101128990B1 (ko) | 2012-03-23 |
Family
ID=44048348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090099930A Active KR101128990B1 (ko) | 2009-10-20 | 2009-10-20 | 피부 미백 효능을 가지는 식물 추출물로 이루어진 조성물 및 이를 포함하는 화장료 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101128990B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160074732A (ko) | 2014-12-17 | 2016-06-29 | 순천향대학교 산학협력단 | 구슬꽃 나무 추출물을 포함하는 피부 미백용 화장료 조성물 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101725969B1 (ko) * | 2013-12-31 | 2017-04-11 | 주식회사 풀무원 | 미백효과를 가지는 복합 약재 추출물을 함유하는 화장료 조성물 |
KR101968626B1 (ko) * | 2018-10-02 | 2019-04-15 | 박노수 | 한약처방을 포함하는 피부 미백용 조성물 및 이의 제조 방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10203948A (ja) | 1997-01-21 | 1998-08-04 | Pola Chem Ind Inc | メラニン産生抑制剤および皮膚外用剤 |
KR100206538B1 (ko) * | 1996-12-21 | 1999-07-01 | 임병철 | 상황버섯 분말 추출물을 함유하는 피부 미백용 화장료 조성물 |
JP2003183123A (ja) * | 2001-10-10 | 2003-07-03 | Masao Takita | 美白性皮膚外用剤およびその製造方法 |
JP2005029490A (ja) * | 2003-07-10 | 2005-02-03 | Sosin:Kk | チロシナーゼ阻害剤、活性酸素抑制剤及び皮膚外用剤 |
-
2009
- 2009-10-20 KR KR1020090099930A patent/KR101128990B1/ko active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100206538B1 (ko) * | 1996-12-21 | 1999-07-01 | 임병철 | 상황버섯 분말 추출물을 함유하는 피부 미백용 화장료 조성물 |
JPH10203948A (ja) | 1997-01-21 | 1998-08-04 | Pola Chem Ind Inc | メラニン産生抑制剤および皮膚外用剤 |
JP2003183123A (ja) * | 2001-10-10 | 2003-07-03 | Masao Takita | 美白性皮膚外用剤およびその製造方法 |
JP2005029490A (ja) * | 2003-07-10 | 2005-02-03 | Sosin:Kk | チロシナーゼ阻害剤、活性酸素抑制剤及び皮膚外用剤 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160074732A (ko) | 2014-12-17 | 2016-06-29 | 순천향대학교 산학협력단 | 구슬꽃 나무 추출물을 포함하는 피부 미백용 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20110043019A (ko) | 2011-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9364423B2 (en) | Whitening agent, anti-aging agent, and antioxidant agent | |
CN102573786A (zh) | 皮肤外用剂、美白剂、抗氧化剂和抗老化剂 | |
KR100920896B1 (ko) | 블루로터스 및 테트라하이드로커큐민을 유효성분으로함유하는 피부 미백용 화장료 조성물 | |
KR102791762B1 (ko) | 락토바실러스 브레비스 균주를 이용하여 발효시킨 작약꽃, 회화나무꽃, 푸른연꽃, 샤프란꽃, 수레국화꽃 혼합추출물을 유효성분으로 함유하는 미백에 효능을 갖는 화장료 조성물 | |
KR101128990B1 (ko) | 피부 미백 효능을 가지는 식물 추출물로 이루어진 조성물 및 이를 포함하는 화장료 조성물 | |
KR100521768B1 (ko) | 피부미백용 화장료 조성물 | |
KR101558182B1 (ko) | 흰감국 추출물을 함유하는 피부 외용제 조성물 | |
KR20100018139A (ko) | 돌나물 추출물 및 리포익산-peg 콘쥬게이트를 함유하는피부외용제 조성물 | |
KR101017586B1 (ko) | 피부 미백용 화장료 조성물 | |
KR100563547B1 (ko) | 싸리나무 및/또는 까마중 추출물을 주요 활성성분으로함유하는 화장료 조성물 | |
KR101093901B1 (ko) | 조직배양한 금선련 추출물을 포함하는 화장료 조성물 및 상기 조직배양한 금선련 추출물의 제조방법 | |
KR100829718B1 (ko) | 먼나무 추출물을 유효성분으로 포함하는 피부 미백용화장료 조성물 | |
KR100710657B1 (ko) | 디하이드로퀘세틴을 함유하는 미백 화장료 조성물 | |
KR20020084429A (ko) | 생열귀 추출물을 함유하는 화장료 | |
KR100965085B1 (ko) | 피부 미백용 화장료 조성물 | |
KR20090039008A (ko) | 생약재 추출물을 함유하는 미백 화장료 조성물 | |
KR100877188B1 (ko) | 양성자 빔 처리에 의한 천연물 유래 미백용 화장료 조성물제조 방법 | |
KR101180354B1 (ko) | 흑삼(黑蔘) 추출물을 함유하는 화장료 조성물 | |
KR100983526B1 (ko) | 백수 추출물을 함유하는 화장료 조성물 | |
KR20100016815A (ko) | 돌나물 추출물 및 알부틴을 함유하는 미백 화장료 조성물 | |
KR20070079390A (ko) | 피부 미백용 화장료 조성물 | |
CN120114360A (zh) | 一种美白霜及其制备方法 | |
KR101893824B1 (ko) | 트리텔레이아 익시오이디즈 추출물을 함유하는 화장료 조성물 | |
KR20130024145A (ko) | 피부 미백용 화장료 조성물 및 이의 제조 방법 | |
KR100635784B1 (ko) | 상지 추출물 및 천궁 추출물을 유효성분으로 함유하는피부 미백용 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20091020 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110825 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20120229 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20120314 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20120315 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20150113 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20150113 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160212 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20160212 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20161228 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20161228 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180307 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20180307 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20190107 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20190107 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20200302 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20200302 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20210225 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20220330 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20221228 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20240103 Start annual number: 13 End annual number: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20241231 Start annual number: 14 End annual number: 14 |